vs

Side-by-side financial comparison of Digital Brands Group, Inc. (DBGI) and InMed Pharmaceuticals Inc. (INM). Click either name above to swap in a different company.

Digital Brands Group, Inc. is the larger business by last-quarter revenue ($1.6M vs $820.2K, roughly 2.0× InMed Pharmaceuticals Inc.). InMed Pharmaceuticals Inc. runs the higher net margin — -247.3% vs -1283.8%, a 1036.5% gap on every dollar of revenue. On growth, Digital Brands Group, Inc. posted the faster year-over-year revenue change (-25.1% vs -26.2%). Over the past eight quarters, InMed Pharmaceuticals Inc.'s revenue compounded faster (-16.4% CAGR vs -33.0%).

Fortune Brands Innovations, Inc. is an American manufacturer of home and security products, headquartered in Deerfield, Illinois. Its portfolio of businesses and brands includes Moen and the House of Rohl; outdoor living and security products from Therma-Tru, Larson, Fiberon, Master Lock and SentrySafe; and MasterBrand Cabinets. Fortune Brands is a Fortune 500 company and part of the S&P 400 Index. As of December 31, 2021, the company reported employing approximately 28,000 associates and pos...

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.

DBGI vs INM — Head-to-Head

Bigger by revenue
DBGI
DBGI
2.0× larger
DBGI
$1.6M
$820.2K
INM
Growing faster (revenue YoY)
DBGI
DBGI
+1.1% gap
DBGI
-25.1%
-26.2%
INM
Higher net margin
INM
INM
1036.5% more per $
INM
-247.3%
-1283.8%
DBGI
Faster 2-yr revenue CAGR
INM
INM
Annualised
INM
-16.4%
-33.0%
DBGI

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
DBGI
DBGI
INM
INM
Revenue
$1.6M
$820.2K
Net Profit
$-20.6M
$-2.0M
Gross Margin
-77.1%
22.5%
Operating Margin
-1385.4%
-247.3%
Net Margin
-1283.8%
-247.3%
Revenue YoY
-25.1%
-26.2%
Net Profit YoY
-283.4%
21.2%
EPS (diluted)
$0.73
$-0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBGI
DBGI
INM
INM
Q4 25
$1.6M
$820.2K
Q3 25
$1.7M
$1.1M
Q2 25
$2.3M
$1.3M
Q1 25
$1.9M
$1.3M
Q4 24
$2.1M
$1.1M
Q3 24
$2.4M
$1.3M
Q2 24
$3.4M
$1.3M
Q1 24
$3.6M
$1.2M
Net Profit
DBGI
DBGI
INM
INM
Q4 25
$-20.6M
$-2.0M
Q3 25
$-3.5M
$-1.7M
Q2 25
$-2.1M
$-1.8M
Q1 25
$-2.1M
$-2.1M
Q4 24
$-5.4M
$-2.6M
Q3 24
$-3.5M
$-1.7M
Q2 24
$-3.5M
$-1.9M
Q1 24
$-683.7K
$-1.7M
Gross Margin
DBGI
DBGI
INM
INM
Q4 25
-77.1%
22.5%
Q3 25
42.7%
36.0%
Q2 25
31.6%
44.2%
Q1 25
46.6%
13.9%
Q4 24
-35.3%
41.5%
Q3 24
46.0%
39.0%
Q2 24
45.9%
36.3%
Q1 24
48.1%
24.7%
Operating Margin
DBGI
DBGI
INM
INM
Q4 25
-1385.4%
-247.3%
Q3 25
-201.3%
-154.2%
Q2 25
-88.2%
-137.1%
Q1 25
-106.7%
-168.1%
Q4 24
-230.1%
-231.6%
Q3 24
-112.4%
-132.7%
Q2 24
-67.8%
-150.5%
Q1 24
-6.3%
-146.9%
Net Margin
DBGI
DBGI
INM
INM
Q4 25
-1283.8%
-247.3%
Q3 25
-208.7%
-154.2%
Q2 25
-94.1%
-137.1%
Q1 25
-111.7%
-168.1%
Q4 24
-250.7%
-231.6%
Q3 24
-145.1%
-132.7%
Q2 24
-103.4%
-151.0%
Q1 24
-19.1%
-146.9%
EPS (diluted)
DBGI
DBGI
INM
INM
Q4 25
$0.73
$-0.51
Q3 25
$-1.18
$-0.44
Q2 25
$-0.81
$-0.07
Q1 25
$-0.92
$-1.94
Q4 24
$132.02
$-3.64
Q3 24
$-81.53
$-2.71
Q2 24
$-104.18
$2.39
Q1 24
$-23.02
$-3.58

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBGI
DBGI
INM
INM
Cash + ST InvestmentsLiquidity on hand
$1.9M
$7.0M
Total DebtLower is stronger
$6.1M
Stockholders' EquityBook value
$8.8M
$9.6M
Total Assets
$44.5M
$11.2M
Debt / EquityLower = less leverage
0.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBGI
DBGI
INM
INM
Q4 25
$1.9M
$7.0M
Q3 25
$6.7M
$9.4M
Q2 25
$542.6K
$11.1M
Q1 25
$2.2M
$4.7M
Q4 24
$164.4K
$3.5M
Q3 24
$289.3K
$5.6M
Q2 24
$92.8K
$6.6M
Q1 24
$11.3K
Total Debt
DBGI
DBGI
INM
INM
Q4 25
$6.1M
Q3 25
Q2 25
Q1 25
Q4 24
$6.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DBGI
DBGI
INM
INM
Q4 25
$8.8M
$9.6M
Q3 25
$16.0M
$11.6M
Q2 25
$7.1M
$13.4M
Q1 25
$6.2M
$7.0M
Q4 24
$-1.3M
$6.2M
Q3 24
$19.0K
$8.4M
Q2 24
$2.7M
$9.2M
Q1 24
$3.0M
$11.1M
Total Assets
DBGI
DBGI
INM
INM
Q4 25
$44.5M
$11.2M
Q3 25
$41.2M
$13.4M
Q2 25
$27.8M
$15.6M
Q1 25
$27.2M
$9.3M
Q4 24
$19.9M
$8.5M
Q3 24
$23.3M
$10.5M
Q2 24
$24.9M
$11.8M
Q1 24
$24.8M
Debt / Equity
DBGI
DBGI
INM
INM
Q4 25
0.70×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBGI
DBGI
INM
INM
Operating Cash FlowLast quarter
$-4.7M
$-2.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBGI
DBGI
INM
INM
Q4 25
$-4.7M
$-2.4M
Q3 25
$-5.1M
$-1.6M
Q2 25
$-1.6M
$-1.8M
Q1 25
$-4.5M
$-1.7M
Q4 24
$-2.8M
$-2.5M
Q3 24
$-541.6K
$-1.8M
Q2 24
$-1.6M
$-1.0M
Q1 24
$-1.2M
$-1.9M
Free Cash Flow
DBGI
DBGI
INM
INM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-541.6K
Q2 24
$-1.6M
Q1 24
$-1.3M
$-1.9M
FCF Margin
DBGI
DBGI
INM
INM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-22.2%
Q2 24
-47.9%
Q1 24
-35.1%
-165.0%
Capex Intensity
DBGI
DBGI
INM
INM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
0.3%
Q1 24
0.4%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons